Supporting Small Business and Career and Technical Education Act of 2023

H.R. 3507/ S. 1688; H.R. 3238/ S. 1557; S. 1686; H.R. 5689-117; H.R. 4211/S. 2045; H.R. 1311; H.R. 1198/S. 528; H.R. 1730/S. 936; H.R. 4819; H.R. 3181/S. 1523; H.R. 5049/ S.2608; H.R. 5784/S. 2988; H.R. 964/ S. 366; H.R. 3350; Lobbied on the federal government's procurement of architecture services; Lobbied in support of investments in the FY2025 Energy & Water Appropriations bill; Lobbied in support of investments in the FY2025 Interior Appropriations bill; Lobbied in support of investments in the FY2025 Transportation- Housing and Urban Development Appropriations bill; Lobbied in support of investments in the FY2025 Homeland Security Appropriations bill; federal government's procurement of architect.

Client expense: Not reported · Firm income: Not reported

H.R. 3507/ S. 1688; H.R. 3238/ S. 1557; S. 1686; H.R. 5689-117; H.R. 4211/S. 2045; H.R. 1311; H.R. 1198/S. 528; H.R. 1730/S. 936; H.R. 4819; H.R. 3181/S. 1523; H.R. 5049/ S.2608; H.R. 5784/S. 2988; H.R. 964/ S. 366; H.R. 3350; Lobbied on the federal government's procurement of architecture services; Lobbied in support of investments in the FY2025 Energy & Water Appropriations bill; Lobbied in support of investments in the FY2025 Interior Appropriations bill; Lobbied in support of investments in the FY2025 Transportation- Housing and Urban Development Appropriations bill; Lobbied in support of investments in the FY2025 Homeland Security Appropriations bill; federal government's procurement of architect.

Client expense: Not reported · Firm income: Not reported

H.R. 3507/ S. 1688; H.R. 3238/ S. 1557; S. 1686; H.R. 5689-117; H.R. 4211/S. 2045; H.R. 1311; H.R. 1198/S. 528; H.R. 1730/S. 936; H.R. 4819; H.R. 3181/S. 1523; H.R. 5049/ S.2608; H.R. 5784/S. 2988; H.R. 964/ S. 366; H.R. 3350; Lobbied on the federal government's procurement of architecture services; Lobbied in support of investments in the FY2025 Energy & Water Appropriations bill; Lobbied in support of investments in the FY2025 Interior Appropriations bill; Lobbied in support of investments in the FY2025 Transportation- Housing and Urban Development Appropriations bill; Lobbied in support of investments in the FY2025 Homeland Security Appropriations bill; federal government's procurement of architect.

Client expense: Not reported · Firm income: Not reported

H.R. 3507/ S. 1688; H.R. 3238/ S. 1557; S. 1686; H.R. 5689-117; H.R. 4211/S. 2045; H.R. 1311; H.R. 1198/S. 528; H.R. 1730/S. 936; H.R. 4819; H.R. 3181/S. 1523; H.R. 5049/ S.2608; H.R. 5784/S. 2988; H.R. 964/ S. 366; H.R. 3350; Lobbied on the federal government's procurement of architecture services; Lobbied in support of investments in the FY2025 Energy & Water Appropriations bill; Lobbied in support of investments in the FY2025 Interior Appropriations bill; Lobbied in support of investments in the FY2025 Transportation- Housing and Urban Development Appropriations bill; Lobbied in support of investments in the FY2025 Homeland Security Appropriations bill; federal government's procurement of architect.

Client expense: Not reported · Firm income: Not reported

H.R. 3507/ S. 1688; H.R. 3238/ S. 1557; S. 1686; H.R. 5689-117; H.R. 4211/S. 2045; H.R. 1311; H.R. 1198/S. 528; H.R. 1730/S. 936; H.R. 4819; H.R. 3181/S. 1523; H.R. 5049/ S.2608; H.R. 5784/S. 2988; H.R. 964/ S. 366; H.R. 3350; Lobbied on the federal government's procurement of architecture services; Lobbied in support of investments in the FY2025 Energy & Water Appropriations bill; Lobbied in support of investments in the FY2025 Interior Appropriations bill; Lobbied in support of investments in the FY2025 Transportation- Housing and Urban Development Appropriations bill; Lobbied in support of investments in the FY2025 Homeland Security Appropriations bill; federal government's procurement of architect.

Client expense: Not reported · Firm income: Not reported

H.R. 3507/ S. 1688; H.R. 3238/ S. 1557; S. 1686; H.R. 5689-117; H.R. 4211/S. 2045; H.R. 1311; H.R. 1198/S. 528; H.R. 1730/S. 936; H.R. 4819; H.R. 3181/S. 1523; H.R. 5049/ S.2608; H.R. 5784/S. 2988; H.R. 964/ S. 366; H.R. 3350; Lobbied on the federal government's procurement of architecture services; Lobbied in support of investments in the FY2025 Energy & Water Appropriations bill; Lobbied in support of investments in the FY2025 Interior Appropriations bill; Lobbied in support of investments in the FY2025 Transportation- Housing and Urban Development Appropriations bill; Lobbied in support of investments in the FY2025 Homeland Security Appropriations bill; federal government's procurement of architect.

Client expense: Not reported · Firm income: Not reported

Lobbied in support of the College Cost Transparency and Student Protection Act (H.R. 1311), Understanding the True Cost of College Act of 2023 (H.R. 1198/S. 528), the Supporting Small Business and Career and Technical Education Act of 2023 (H.R. 1730/S. 936), the Student Debt Alternative and CTE Awareness Act (H.R. 4819/Rehabilitation of Historic Schools Act of 2023 (H.R. 3181/S. 1523) Lobbied in support of the reintroduction of the Reopen and Rebuild America's Schools Act (H.R. 5049/ S.2608) and Green New Deal for Public Schools Act (H.R. 5784/S. 2988)

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Lobbied in support of the College Cost Transparency and Student Protection Act (H.R. 1311), Understanding the True Cost of College Act of 2023 (H.R. 1198/S. 528), the Supporting Small Business and Career and Technical Education Act of 2023 (H.R. 1730/S. 936), the Student Debt Alternative and CTE Awareness Act (H.R. 4819/Rehabilitation of Historic Schools Act of 2023 (H.R. 3181/S. 1523) Lobbied in support of the reintroduction of the Reopen and Rebuild America's Schools Act (H.R. 5049/ S.2608) and Green New Deal for Public Schools Act (H.R. 5784/S. 2988)

Client expense: $210,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Lobbied in support of the College Cost Transparency and Student Protection Act (H.R. 1311), Understanding the True Cost of College Act of 2023 (H.R. 1198/S. 528), the Supporting Small Business and Career and Technical Education Act of 2023 (H.R. 1730/S. 936), the Student Debt Alternative and CTE Awareness Act (H.R. 4819/Rehabilitation of Historic Schools Act of 2023 (H.R. 3181/S. 1523) Lobbied in support of the reintroduction of the Reopen and Rebuild America's Schools Act (H.R. 5049/ S.2608) and Green New Deal for Public Schools Act (H.R. 5784/S. 2988)

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Lobbied in support of the College Cost Transparency and Student Protection Act (H.R. 1311), Understanding the True Cost of College Act of 2023 (H.R. 1198/S. 528), the Supporting Small Business and Career and Technical Education Act of 2023 (H.R. 1730/S. 936), the Student Debt Alternative and CTE Awareness Act (H.R. 4819/Rehabilitation of Historic Schools Act of 2023 (H.R. 3181/S. 1523) Lobbied in support of the reintroduction of the Reopen and Rebuild America's Schools Act (H.R. 5049/ S.2608) and Green New Deal for Public Schools Act (H.R. 5784/S. 2988)

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Lobbied in support of the College Cost Transparency and Student Protection Act (H.R. 1311), Understanding the True Cost of College Act of 2023 (H.R. 1198/S. 528), the Supporting Small Business and Career and Technical Education Act of 2023 (H.R. 1730/S. 936), the Student Debt Alternative and CTE Awareness Act (H.R. 4819/Rehabilitation of Historic Schools Act of 2023 (H.R. 3181/S. 1523) Lobbied in support of the reintroduction of the Reopen and Rebuild America's Schools Act (H.R. 5049/ S.2608) and Green New Deal for Public Schools Act (H.R. 5784/S. 2988)

Client expense: $210,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Lobbied in support of the College Cost Transparency and Student Protection Act (H.R. 1311), Understanding the True Cost of College Act of 2023 (H.R. 1198/S. 528), the Supporting Small Business and Career and Technical Education Act of 2023 (H.R. 1730/S. 936), the Student Debt Alternative and CTE Awareness Act (H.R. 4819/Rehabilitation of Historic Schools Act of 2023 (H.R. 3181/S. 1523) Lobbied in support of the reintroduction of the Reopen and Rebuild America's Schools Act (H.R. 5049/ S.2608) and Green New Deal for Public Schools Act (H.R. 5784/S. 2988)

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Lobbied in support of the College Cost Transparency and Student Protection Act (H.R. 1311), Understanding the True Cost of College Act of 2023 (H.R. 1198/S. 528), the Supporting Small Business and Career and Technical Education Act of 2023 (H.R. 1730/S. 936), the Student Debt Alternative and CTE Awareness Act (H.R. 4819/Rehabilitation of Historic Schools Act of 2023 (H.R. 3181/S. 1523) Lobbied in support of the reintroduction of the Reopen and Rebuild America's Schools Act (H.R. 5049/ S.2608) and Green New Deal for Public Schools Act (H.R. 5784/S. 2988)

Client expense: $260,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Lobbied in support of the College Cost Transparency and Student Protection Act (H.R. 1311), Understanding the True Cost of College Act of 2023 (H.R. 1198/S. 528), the Supporting Small Business and Career and Technical Education Act of 2023 (H.R. 1730/S. 936), the Student Debt Alternative and CTE Awareness Act (H.R. 4819/Rehabilitation of Historic Schools Act of 2023 (H.R. 3181/S. 1523) Lobbied in support of the reintroduction of the Reopen and Rebuild America's Schools Act (H.R. 5049/ S.2608) and Green New Deal for Public Schools Act (H.R. 5784/S. 2988)

Client expense: $260,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Lobbied in support of the College Cost Transparency and Student Protection Act (H.R. 1311), Understanding the True Cost of College Act of 2023 (H.R. 1198/S. 528), the Supporting Small Business and Career and Technical Education Act of 2023 (H.R. 1730/S. 936), the Student Debt Alternative and CTE Awareness Act (H.R. 4819/Rehabilitation of Historic Schools Act of 2023 (H.R. 3181/S. 1523) Lobbied in support of the reintroduction of the Reopen and Rebuild America's Schools Act (H.R. 5049/ S.2608) and Green New Deal for Public Schools Act (H.R. 5784/S. 2988)

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Lobbied in support of the College Cost Transparency and Student Protection Act (H.R. 1311), Understanding the True Cost of College Act of 2023 (H.R. 1198/S. 528), the Supporting Small Business and Career and Technical Education Act of 2023 (H.R. 1730/S. 936), the Student Debt Alternative and CTE Awareness Act (H.R. 4819/Rehabilitation of Historic Schools Act of 2023 (H.R. 3181/S. 1523) Lobbied in support of the reintroduction of the Reopen and Rebuild America's Schools Act (H.R. 5049/ S.2608) and Green New Deal for Public Schools Act (H.R. 5784/S. 2988)

Client expense: $150,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Providing information surrounding the benefits of supporting career and technical education; Supporting the Jumpstart Our Businesses by Supporting Students Act (S. 161/H.R. 793); Supporting the operations of the House Career and Technical Education Caucus; Supporting the operations of the Senate Career and Technical Education Caucus; Supporting the RAISE Act (S. 1584/H.R. 3264); Supporting the Loan Forgiveness for Educators Act (H.R. 1757/S. 963); Promoting CTE teacher pipeline issues at the secondary and postsecondary level; Supporting the Supporting Small Business and Career and Technical Education Act of 2023 (H.R. 1730/S. 936); Supporting the College Transparency Act (H.R. 2957/S. 1349); Supporting the Retaining Educators Takes Added Investment Now (RETAIN) Act (H.R. 3265/S. 1567); Supporting the Making Education Affordable and Accessible Act of 2023 (S. 1092); Supporting the Freedom to Invest in Tomorrows Workforce Act (S. 722/H.R. 1477); Supporting the Tax Free Pell (H.R. 3000); Supporting the Preparing and Retaining Education Professionals (PREP) Act (S. 2244); Providing input into the reauthorization of the Education Sciences Reform Act; Providing feedback on Carl D. Perkins Career and Technical Education Act state plan requirements; Supporting the COTA Act (H.R. 4945), providing input into the Rural Health Workforce Pathway Act (under development), providing input into the Green Workforce Act (under development); providing input into the Supporting Teaching and Learning through Better Data Act (S. 2065).

Client expense: $60,000 · Firm income: Not reported

Lobbied in support of the College Cost Transparency and Student Protection Act (H.R. 1311), Understanding the True Cost of College Act of 2023 (H.R. 1198/S. 528), the Supporting Small Business and Career and Technical Education Act of 2023 (H.R. 1730/S. 936), the Student Debt Alternative and CTE Awareness Act (H.R. 4819/Rehabilitation of Historic Schools Act of 2023 (H.R. 3181/S. 1523) Lobbied in support of the reintroduction of the Reopen and Rebuild America's Schools Act (H.R. 5049/ S.2608) and Green New Deal for Public Schools Act (H.R. 5784/S. 2988)

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Lobbied in support of the College Cost Transparency and Student Protection Act (H.R. 1311), Understanding the True Cost of College Act of 2023 (H.R. 1198/S. 528), the Supporting Small Business and Career and Technical Education Act of 2023 (H.R. 1730/S. 936), the Student Debt Alternative and CTE Awareness Act (H.R. 4819/Rehabilitation of Historic Schools Act of 2023 (H.R. 3181/S. 1523) Lobbied in support of the reintroduction of the Reopen and Rebuild America's Schools Act (H.R. 5049/ S.2608) and Green New Deal for Public Schools Act (H.R. 5784/S. 2988)

Client expense: $230,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Providing information surrounding the benefits of supporting career and technical education; Supporting the Jumpstart Our Businesses by Supporting Students Act (S. 161/H.R. 793); Supporting the operations of the House Career and Technical Education Caucus; Supporting the operations of the Senate Career and Technical Education Caucus; Supporting the RAISE Act (S. 1584/H.R. 3264); Supporting the Loan Forgiveness for Educators Act (H.R. 1757/S. 963); Promoting CTE teacher pipeline issues at the secondary and postsecondary level; Supporting the Supporting Small Business and Career and Technical Education Act of 2023 (H.R. 1730/S. 936); Supporting the College Transparency Act (H.R. 2957/S. 1349); Supporting the Retaining Educators Takes Added Investment Now (RETAIN) Act (H.R. 3265/S. 1567); Supporting the Making Education Affordable and Accessible Act of 2023 (S. 1092); Supporting the Freedom to Invest in Tomorrows Workforce Act (S. 722/H.R. 1477); Supporting the Tax Free Pell (H.R. 3000); Supporting the Preparing and Retaining Education Professionals (PREP) Act (S. 2244); Providing input into the reauthorization of the Education Sciences Reform Act; Providing feedback on Carl D. Perkins Career and Technical Education Act state plan requirements.

Client expense: $60,000 · Firm income: Not reported

Lobbied in support of the College Cost Transparency and Student Protection Act (H.R. 1311), the Supporting Small Business and Career and Technical Education Act of 2023 (H.R. 1730/S. 936), Rehabilitation of Historic Schools Act of 2023 (H.R. 3181). Lobbied in support of the reintroduction of the Reopen and Rebuild America's Schools Act (H.R. 604/ S.96--117) and an amended version of the STOP II Act (H.R. 7966).

Client expense: $270,000 · Firm income: Not reported

Government targets: Education, Dept of, HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE

Providing information surrounding the benefits of supporting career and technical education; Supporting the Jumpstart Our Businesses by Supporting Students Act (S. 161/H.R. 793); Supporting the operations of the House Career and Technical Education Caucus; Supporting the operations of theSenate Career and Technical Education Caucus; Supporting the RAISE Act (H.R. 7660, S. 4125 in 117th Congress); Supporting the LoanForgiveness for Educators Act (S. 963); Promoting CTE teacher pipeline issues at the secondary and postsecondary level; Supporting resolutions for CTE Month (H.Res.110/S.Res.67); Supporting the Supporting Small Business and Career and Technical Education Act of 2023 (H.R. 1730/S. 936); Supporting the Making Education Affordable and Accessible Act of 2023 (S. 1092); Providing feedback on Carl D. Perkins Career and Technical Education Act state plan requirements.

Client expense: $60,000 · Firm income: Not reported

Government targets: Education, Dept of, HOUSE OF REPRESENTATIVES, SENATE

340B Drug Discount Program ---340B Accountability Act ---Executive Order on Access to Affordable Life-Saving Medications ---Program Implementation & Oversight ---PROTECT 340B Act Accelerated Approval Alternative Funding Programs Biodefense Research, Development and Procurement Issues (Non-Funding) ---American Pandemic Preparedness Plan (AP3) ---Disease X ---Implementation of the Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 ---MCM PRV Program ---Reauthorization of PAHPA ---Tropical Disease Priority Review Voucher (PRV) Program ---White House National Biodefense Strategy Biosimilars ---BIOSIM Act ---BSUFA Negotiations ---Coding ---Implementation and Reauthorization of the Biosimilar User Fee Act of 2022 ---Interchangeability and Pharmacy Substitution ---Protecting Consumer Access to Generic Drugs Act ---Reimbursement Coronavirus (COVID-19) Pandemic ---H.R.834: Pandemics Require Evaluating, Planning, And Responding Effectively (PREPARE) Act ---H.R.2617: Consolidated Appropriations Act of 2023 ---S.2327: Seniors Prescription Drug Relief Act ---S.3799: Prepare for and Respond to Existing Viruses, Emerging New Threats and (PREVENT) Pandemics Act ---S.4317: SAFE TO WORK Act ---S.4509: Vaccine And Coverage Certainty (VACC) Act ---Access to Generic Drugs Act of 2021 ---COVID-19 Lessons Learned ---COVID-19 Pricing-Related Provisions ---COVID-19 Vaccine Distribution ---Defense Production Act (DPA) ---Drug Supply Chain Management ---Healthcare Disparities ---Medicare Reimbursement Policies ---Monoclonal Antibody Coverage and Utilization ---Patient Cost-Sharing and Smoothing ---R&D Funding for Medical Countermeasures ---Restrictions on Intellectual Property Rights ---Senate HELP Pandemic Preparedness White Paper ---Supply Chain Issues ---Temporarily Refundable R&D Credit ---TRIPS Waiver ---WHO Pandemic Preparedness Accord Climate Change ---H.R.2617: Consolidated Appropriations Act of 2023 ---Implementation of the Inflation Reduction Act (IRA) of 2022 Data Privacy ---H.R.8152: American Data Privacy and Protection Act Diagnostics and Personalized Medicine Regulation and Oversight Diversity & Inclusion ---S.3799: Prepare for and Respond to Existing Viruses, Emerging New Threats and (PREVENT) Pandemics Act ---Decentralized Clinical Trials Drug Evaluation and Review ---COVID-19 Lessons Learned ---FDA Management and Financial Accountability Drug Importation Drug Manufacturing, Quality & Distribution ---Advanced Manufacturing ---Counterfeiting ---Drug Shortages ---Executive Order on Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe, and Secure American Bioeconomy ---Supply Chain Integrity and Traceability Drug Patenting ---H.R.2883/S.1485: Stop Stalling Access to Affordable Medications ---H.R.2891/S.1428: Preserve Access to Affordable Generics and Biosimilars Act ---S.79/H.R.1717: Interagency Patent Coordination and Improvement Act of 2023 ---S.113: Prescription Pricing for the People Act of 2023 ---S.142: Preserve Access to Affordable Generics and Biosimilars Act ---S.148: Stop STALLING Act ---S.150: Affordable Prescriptions for Patients Act of 2023 ---S.1128 118th Congress (2023-2024): A bill to establish special rules relating to information provided with respect to drug applications concerning method of use patents ---Affordable Prescriptions for Patients Act ---Interagency Patent Coordination and Improvement Act ---Restrictions on Intellectual Property Rights Drug Pricing ---H.R.1790: Biologics Competition Act of 2023 ---H.R.2139/S.908: Medicare Drug Price Negotiation Act ---H.R.2148/S.909: Prescription Drug Price Relief Act ---H.R.2617: Consolidated Appropriations Act of 2023 ---S.79/H.R.1717: Interagency Patent Coordination and Improvement Act of 2023 ---S.113: Prescription Pricing for the People Act of 2023 ---S.142: Preserve Access to Affordable Generics and Biosimilars Act ---S.148: Stop STALLING Act ---S.150: Affordable Prescriptions for Patients Act of 2023 ---S.775: Increasing Transparency in Generic Drug Application ---S.1067: Ensuring Timely Access to Generics ---S.1128 118th Congress (2023-2024): A bill to establish special rules relating to information provided with respect to drug applications concerning method of use patents ---Access to Innovative Treatments Act ---Affordable Prescriptions for Patients Act ---COVID-19 Pricing-Related Provisions ---Implementation of the Inflation Reduction Act (IRA) of 2022 ---Lower Costs, More Cures Act ---National Coverage Determination ---Pharmacy Benefit Manager Transparency Act ---Prescription Pricing for the People Act Foreign Drug Data Protection Laws Funding for Antimicrobial Resistance (AMR) Programs ---FY 2024 Appropriations ---H.R.2617: Consolidated Appropriations Act of 2023 ---National Defense Authorization Act for FY 2023 ---DISARM Act ---Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement ---FY 2024 Appropriations ---H.R.2617: Consolidated Appropriations Act of 2023 ---Funding for Strategic National Stockpile ---Health Defense Operations Funding Designation ---Implementation of the Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 ---Implementation of the Inflation Reduction Act (IRA) of 2022 ---Reauthorization of PAHPA Funding for FDA ---FY 2024 Appropriations ---H.R.2617: Consolidated Appropriations Act of 2023 ---H.R.7667: The Food and Drug Amendments of 2022 ---H.R.8239: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act ---S.4348: Food and Drug Administration Safety and Landmark Advancements Act of 2022 ---Prescription Drug User Fee Act (PDUFA) VII Priorities Funding for Health Resources and Services Administration (HRSA) ---H.R.2617: Consolidated Appropriations Act of 2023 Funding for National Institutes of Health ---FY 2024 Appropriations ---H.R.2617: Consolidated Appropriations Act of 2023 ---Advanced Research Projects Agency for Health (ARPA-H) Act Funding for the Centers for Disease Control and Prevention Vaccine Programs ---FY 2024 Appropriations ---H.R.2617: Consolidated Appropriations Act of 2023 ---Funding for 2022-2023 Influenza Season Preparedness and Response ---Funding for Routine Immunization Infrastructure during Pandemic ---Implementation of the Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 Funding for the HHS Office of Infectious Disease and HIV/AIDS Policy ---FY 2024 Appropriations ---H.R.2617: Consolidated Appropriations Act of 2023 Generic Drug Entry ---S.148: Stop STALLING Act ---Bringing Low-cost Options and Competition while Keeping Incentives for New Generics (BLOCKING) Act ---Enhanced Access to Affordable Medicines Act ---Generic Drug Application Review Reforms ---Increasing Transparency in Generic Drug Applications Act ---Incentives for Generic Entry Medicaid ---Alternative Payment Arrangements for Gene Therapies ---Average Manufacturer Price Calculations ---Coverage of Accelerated Approval Products ---Drug Benefit Design ---Medicaid VBPs for Patients (MVP) Act ---Pharmacy Benefit Manager Transparency Act ---Pricing and Rebates ---Value-Based Purchasing (VBP) Rule Opioid Crisis ---Coverage and Reimbursement ---Non-Opioid Analgesics Orphan Drug Issues ---H.R.5566: Finding Orphan-Disease Remedies with Antifungal Research and Development (FORWARD) Act ---S.4185: Retaining Access and Restoring Exclusivity (RARE) Act ---Implementation of the Inflation Reduction Act (IRA) of 2022 ---Orphan Drug Tax Credit Rare Pediatric Disease Priority Review ---H.R.6888/S.4071: Helping Experts Accelerate Rare Treatments (HEART) Act ---H.R.1730: Speeding Therapy Access Today (STAT) Act Reimbursement and Coverage of Innovative Products ---H.R.2139/S.908: Medicare Drug Price Negotiation Act ---H.R.2148/S.909: Prescription Drug Price Relief Act ---H.R.9127: Mandating Exclusive Review of Individual Treatments (MERIT) Act ---S.2327: Seniors Prescription Drug Relief Act ---Access to Innovative Treatments Act ---Administration Rebate Rule ---CMMI Authority ---Implementation of the Inflation Reduction Act (IRA) of 2022 ---In-Home Administration of Part B Drugs ---Lower Costs, More Cures Act ---National Coverage Determination ---Patient Cost-Sharing and Smoothing Vaccines and Infectious Diseases ---FY 2024 Appropriations ---H.R.2617: Consolidated Appropriations Act of 2023 ---H.R.9127: Mandating Exclusive Review of Individual Treatments (MERIT) Act ---S.4509: Vaccine and Coverage Certainty (VACC) Act ---Access to Innovative Treatments Act ---Adult Immunization ---DISARM Act ---Maternal Immunization ---MCM Manufacturing & Capacity ---MCM R&D Incentives ---Monoclonal Antibody Coverage and Utilization ---National Coverage Determination ---Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) ---Vaccine and Antimicrobial Resistance Product Development and Incentives ---Vaccine Injury Compensation Modernization Act ---Vaccine Injury Compensation Program ---Vaccine Quality Measure ---Vaccine Safety Vaccine Injury Compensation Program ---FY 2024 Appropriations ---H.R.2617: Consolidated Appropriations Act of 2023 ---S.3810: Countermeasure Injury Compensation Fund Amendment Act ---Vaccine Access Improvement Act ---Vaccine Injury Compensation Modernization Act ---VICP CICP (Discussion Draft)